{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:51:05Z","timestamp":1791060665842,"version":"4.1.0"},"reference-count":21,"publisher":"National Institute of Industrial Health","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ind Health"],"published-print":{"date-parts":[[2008]]},"DOI":"10.2486\/indhealth.46.484","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T05:52:27Z","timestamp":1223445147000},"page":"484-489","source":"Crossref","is-referenced-by-count":60,"title":["Increased 8-isoprostane, a Marker of Oxidative Stress in Exhaled Breath Condensate in Subjects with Asbestos Exposure"],"prefix":"10.2486","volume":"46","author":[{"given":"Daniela","family":"PELCLOV\u00c1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"FENCLOV\u00c1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"KA\u010cER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"KUZMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"NAVR\u00c1TIL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jind\u0159i\u0161ka","family":"LEBEDOV\u00c1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT (2003) Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Rad Biol Med 34, 117-1129.","DOI":"10.1016\/S0891-5849(03)00060-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kopnin PB, Kravchenko IV, Furalyov VA, Pylev LN, Kopnin BP (2004) Cell type-specific effects of asbestos on intracellular ROS levels, DNA oxidation and G1 cell cycle checkpoint. Oncogene 23, 8834-40.","DOI":"10.1038\/sj.onc.1208108"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Dopp E, Yadav S, Ansari FA, Bhattacharya K, von Recklinghausen U, Rauen U, Rödelsperger K, Shokouhi B, Geh S, Rahman Q (2005) ROS-mediated genotoxicity of asbestos-cement in mammalian lung cells in vitro. Part Fibre Toxicol 2, 2-9.","DOI":"10.1186\/1743-8977-2-9"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.2174\/138161206776055985"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Barnes PJ (2005) Exhaled breath condensate: a new approach to monitoring lung inflammation. In: New perspectives in monitoring lung inflammation. Analysis of exhaled breath condensate. Montuschi P (Ed.), 1-9, CRC Press, Boca Raton.","DOI":"10.3109\/9780203022153-2"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.6.505"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2006.01636.x"},{"key":"8","unstructured":"8) Pelclová D, Fenclová Z, Kačer P, Kuzma M, Lebedová J, Klusáčková P, Balíková M, Navrátil T (2005) Exhaled breath condensate in asbestos exposure. CHEST 128 (Suppl), 345-6."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Lehtonen H, Oksa P, Lehtimäki L, Sepponen A, Nieminen R, Kankaanranta H, Saarelainen S, Järvenpää R, Uitti J, Moilanen E (2007) Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax 62, 602-7.","DOI":"10.1136\/thx.2006.067868"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Heinrich-Ramm R, Wegner R, Garde AH, Baur X (2002) Cotinine excretion (tobacco smoke biomarker) of smokers and non-smokers: comparison of GC\/MS and RIA results. Int J Hyg Environ Health 205, 493-9.","DOI":"10.1078\/1438-4639-00173"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-006-0091-x"},{"key":"12","unstructured":"12) Guidelines for the use of ILO international classification of radiographs of pneumoconiosis 22, 1980. Revised edition. Geneva, ILO 1980."},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.02.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mulgrew AT, Taggart CC, Lawless MW (2004) Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 125, 1952-7.","DOI":"10.1378\/chest.125.5.1952"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.3200\/AEOH.58.10.662-668"},{"issue":"8","key":"16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/002215549804600803","volume":"46","author":"BERGGARD T","year":"1998","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1554","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Patrignani P, Tacconelli S (2005) Isoprostanes and other markers of peroxidation in atherosclerosis. Biomarkers 10 (Suppl 1), 24-9.","DOI":"10.1080\/13547500500215084"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00029705"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Rosias PP, Robroeks CMN, Niemarkt HJ, Kester AD, Vernooy JH, Suykerbuyk J, Teunissen J, Heynens J, Hendriks HJ, Höbsis Q, Dompeling E (2006) Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J 28, 1036-41.","DOI":"10.1183\/09031936.06.00110305"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Montuschi P (2007) Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Therap Adv Respir Dis 1, 5-23.","DOI":"10.1177\/1753465807082373"},{"key":"21","unstructured":"21) Pelclová D, Fenclová Z, Kačer P, Kuzma M, Navrátil T, Lebedová J, Klusáčková P (2007) Arachidonic acid derivatives in the exhaled breath condensate in pneumoconioses and their correlation with individual factors. Chem Listy 101, s144-6."}],"container-title":["Industrial Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/indhealth\/46\/5\/46_5_484\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T15:27:41Z","timestamp":1621524461000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/indhealth\/46\/5\/46_5_484\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.2486\/indhealth.46.484","relation":{},"ISSN":["0019-8366","1880-8026"],"issn-type":[{"value":"0019-8366","type":"print"},{"value":"1880-8026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}